Centogene (NASDAQ:CNTG – Get Free Report) traded down 1.6% during trading on Friday . The company traded as low as $0.34 and last traded at $0.34. 69,048 shares were traded during trading, a decline of 30% from the average session volume of 98,141 shares. The stock had previously closed at $0.35.
Centogene Stock Performance
The business has a 50-day moving average of $0.41 and a two-hundred day moving average of $0.64.
Centogene Company Profile
Centogene N.V., together with its subsidiaries, provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific. The company offers data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases.
Read More
- Five stocks we like better than Centogene
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- Using the MarketBeat Dividend Tax Calculator
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Receive News & Ratings for Centogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centogene and related companies with MarketBeat.com's FREE daily email newsletter.
